In a model of acute pancreatitis, lung inflammation was less in Tpl2-/-mice [31], and in a model of experimental colitis, Tpl2-/-mice and mice treated with a Tpl2 inhibitor had less bowel inflammation [32]. Here, MAP3K8 is linked to inflammation.